Autolus Therapeutics Ltd | AUTL - Aktiva

Keuangan

USD

USD 589.07M

USD 104.13M

Biaya Penjualan

USD 25.33M

USD 435.92M

Kewajiban Lancar

USD 73.44M

USD 253.44M

USD -72.47M

USD -70.08M

Eps Laba Per Saham

USD -0.34

Modal Dan Cadangan

USD 178.13M

Laba Kotor Pada Penjualan

USD -7.45M

Beban Bunga Utang

USD 10.52M

Pendapatan Bunga

USD 6.14M

USD 251.95M

Kapitalisasi Pasar

USD 433.81M

Batas Pemasukan

USD -90.33M

Biaya Operasional

USD 96.76M

Laba Operasional

USD -72.47M

Modal Saham Biasa

USD 266.14M

Laba Sebelum Pajak

USD -91.52M

Pendapatan Penjualan

USD 24.29M

Beban Penjualan Dan Administrasi

USD 35.79M

USD 33.21M

Kreditur Perdagangan

USD 3.08M

Debitur Perdagangan

USD 91.36M

	Aktiva	Perubahan		Tanggal
AstraZeneca	USD 114.07B		382M	2025-12
Autolus Therapeutics Ltd	USD 589.07M		72.88M	2025-12
Hikma Pharmaceutical	USD 5.67B		117M	2025-12
Novartis	USD 110.95B		3.66B	2025-12
Roche Holding	CHF 100.7B		5.94B	2025-12
Silence Therapeutics	USD 131.44M		15.35M	2025-12